Search

Your search keyword '"Merchan-Gomez S"' showing total 18 results
Start Over Author "Merchan-Gomez S"
18 results on '"Merchan-Gomez S"'

1. SCAI SHOCK stage classification: valid for all indications and devices in patients with short-term mechanical circulatory support?

Author

Hernandez Martos, A, primary, Alonso Fernandez De Gatta, M, additional, Diego Nieto, A, additional, Gonzalez Cebrian, M, additional, Toranzo Nieto, I, additional, Barrio Rodriguez, A, additional, Martin Herrero, F, additional, Merchan Gomez, S, additional, Gonzalez Calle, D, additional, Hernandez Hidalgo, M, additional, Barreira De Sousa, G J, additional, De Avila Neila, A, additional, and Sanchez Fernandez, P L, additional

Published
2024
Full Text
View/download PDF

3. Prognostic factors and mortality predictive scale in patients treated with in-hospital extracorporeal cardiopulmonary resuscitation

Author

Alonso Fernandez De Gatta, M, primary, Hernandez Martos, A V, additional, Diego Nieto, A, additional, Merchan Gomez, S, additional, Martin Herrero, F, additional, Gonzalez Cebrian, M, additional, Toranzo Nieto, I, additional, Barrio Rodriguez, A, additional, Cid Menendez, A, additional, Gonzalez Calle, D, additional, and Sanchez, P L, additional

Published
2023
Full Text
View/download PDF

4. Nosocomial infections in patients requiring short-term mechanical circulatory support: characteristics, risk factors and prognosis

Author

Hernandez Martos, A V, primary, Alonso Fernandez De Gatta, M, additional, Martin Herrero, F, additional, Moreta Matilla, M, additional, Diego Nieto, A, additional, Merchan Gomez, S, additional, Gonzalez Cebrian, M, additional, Toranzo Nieto, I, additional, Barrio Rodriguez, A, additional, Cid Menendez, A, additional, Gonzalez Calle, D, additional, Barreira De Sousa, G J, additional, Cruz Galban, A, additional, Hernandez Hidalgo, M, additional, and Sanchez Fernandez, P L, additional

Published
2023
Full Text
View/download PDF

5. Prophylaxis and treatment of nosocomial infections in patients under short-term mechanical circulatory support

Author

Alonso Fernandez De Gatta, M, primary, Hernandez Martos, A V, additional, Esteban Milla, L, additional, Martin Herrero, F, additional, Moreta Matilla, M, additional, Diego Nieto, A, additional, Merchan Gomez, S, additional, Gonzalez Cebrian, M, additional, Toranzo Nieto, I, additional, Barrio Rodriguez, A, additional, Cid Menendez, A, additional, Gonzalez Calle, D, additional, Barreira De Sousa, G, additional, Cruz Galban, A, additional, and Sanchez Fernandez, P L, additional

Published
2023
Full Text
View/download PDF

6. Prognostic factors in real-world elective supported high risk percutaneous coronary intervention with pLVAD or ECMO

Author

Antunez Ballesteros, M, primary, Alonso Fernandez De Gatta, M, additional, Diego Nieto, A, additional, Merchan Gomez, S, additional, Garcia Monsalvo, M, additional, Blanco Fernandez, F, additional, Elvira Laffond, A, additional, Cabanas Tendero, O, additional, Oviedo Rodriguez, JD, additional, Nunez Garcia, JC, additional, Barrio Rodriguez, A, additional, Martin Herrero, F, additional, Gonzalez Cebrian, M, additional, Toranzo Nieto, I, additional, and Sanchez Fernandez, PL, additional

Published
2022
Full Text
View/download PDF

7. Echocardiographic recovery changes in patients supported with veno-arterial extracorporeal membrane oxygenator and weaning success

Author

Gonzalez Martin, J, primary, Alonso-Fernandez-Gatta, M, additional, Merchan Gomez, S, additional, Gonzalez Cebrian, M, additional, Diego-Nieto, A, additional, Martin-Herrero, F, additional, Toranzo-Nieto, I, additional, Barrio-Rodriguez, A, additional, Rodriguez-Estevez, L, additional, and Sanchez-Fernandez, P L, additional

Published
2021
Full Text
View/download PDF

11. 16Beyond coronary disease: an unexpected diagnose with CT scan

Author

Ramis Barcelo, M F, primary, Martin Garcia, A, additional, Matajira Chia, T, additional, Barreiro Perez, M F, additional, Moya Martin, A I, additional, Mas Llado, C, additional, Castillo, Y, additional, Diaz Pelaez, E, additional, Merchan Gomez, S, additional, Cambronero, E, additional, and Sanchez, P L, additional

Published
2019
Full Text
View/download PDF

14. Poster session 6

Author

Lofmark, H, Winter, R, Moukarzel, JA, Filipuzzi, JM, Vaisbuj, F, Salmo, F, Guevara, E, Barbier, P, Savioli, G, Keramida, K, Kouris, N, Dawson, D, Olympios, CD, Nihoyannopoulos, P, Meel, R, Peters, F, Libhaber, E, Nel, S, Goncalves, R, Essop, MR, Dinis, P G, Teixeira, R, Madeira, M, Cachulo, MC, Goncalves, L, Jorstig, S, Emilsson, K, Waldenborg, M, Liden, M, Wodecki, M, Thunberg, P, Perez, Valverde, Sotelo, J, Beerbaum, P, Grotenhuis, H, Greil, G, Razavi, R, Uribe, S, Figueroa, A, Zemedkun, M, Wang, Z, Asch, FM, Gizzi, G, Fabiani, D, Lavorgna, A, Napoletano, C, Saha, S K, Muthukumar, L, Englund, E, Toole, R, Gopal, AS, Di Salvo, G, Issa, Z, Moiduddin, N, Siblini, G, Bulbul, Z, Yurdakul, SELEN, Ercan, G, Tekkesin, ILKER, Sahin, ST, Cengiz, B, Celik, G, Demircan, SABRI, Aytekin, SAIDE, Chumarnaya, T, Alueva, Y, Kochmasheva, VV, Solovyova, O, Tuset, L, Maceira Gonzalez, A M, Igual, B, Bruin De- Bon, HACM, Cocchieri, R, Wagner, GS, Eberl, S, Brink Van Den, RBA, Bouma, BJ, Onishi, T, Kawai, H, Tanaka, H, Fujiwara, S, Hirata, K, Marketou, M, Parthenakis, F, Kontaraki, J, Patrianakos, A, Nakou, H, Maragkoudakis, S, Vougia, D, Logakis, J, Roufas, K, Vardas, P, Bayuga, MT, Ramboyong, RE, Johansson, M C, Wallentin Guron, C, Thurin, A, Wessling, N, Almodares, Q, Fu, M, Mandour Ali, M, Mohamed, LA, Abd Al-Rahman, T, Maghraby, HM, Kora, IM, Abdel-Hameed, FR, Ali, MN, King, GJ, Byrne, D, Bennett, K, Norris, K, Daly, C, Murphy, RT, Marti, G, Degiovanni, A, Di Ruocco, MV, Sartori, C, Devecchi, P, Marino, P, Angelis, A, Aggeli, K, Ioakeimidis, N, Felekos, I, Aznaouridis, K, Rokas, K, Abdelrasoul, M, Terentes, D, Vlachopoulos, C, Tousoulis, D, Spinelli, L, Stabile, E, Santoro, M, Morisco, C, Giudice, C A, Esposito, G, Trimarco, B, Dragoi Galrinho, R, Ciobanu, AO, Rimbas, RC, Manole, GC, Marinescu, B, Vinereanu, D, Krljanac, G, Trifunovic, D, Savic, L, Asanin, M, Lasica, R, Aleksandric, S, Zlatic, N, Petrovic, M, Jovanovic, LJ, Mrdovic, I, Zahidova, K, aethiology, Chronic heart failure of ishemic, anemia, Trifunovic, D, Krljanac, G, Sobic Saranovic, D, Asanin, M, Grozdic Milojevic, I, Savic, L, Vasiljevic, Z, Aleksandric, S, Srdic, M, Mrdovic, I, Mateescu, AD, Calin, A, Rosca, M, Beladan, CC, Enache, R, Gurzun, MM, Varga, P, Calin, C, Ginghina, C, Popescu, BA, Melissopoulou, M, Nguyen, V, Mathieu, T, Attias, D, Dreyfus, J, Codogno, I, Vahanian, A, Messika-Zeitoun, D, study, The COFRASA/GENERAC, Stefanidis, A, Komatanou, E, Anagnostou, E, Armatas, G, Samiotou, D, Papaspyropoulos, A, Philippou, P, Korlou, P, Tzerefos, S, Kranidis, A, Kammerer, I, Wiedemann, M, Sack, FU, Koyama, T, Fukuhara, K, Imai, K, Yamada, R, Kume, T, Neishi, Y, Uemura, S, Pergola, V, Di Salvo, G, Fadel, B, Aladmawi, M, Shahid, M, Alamri, M, Bulbul, Z, Issa, Z, Alhalees, Z, Rafael De La Espriella Juan, RDLE, Rafael Paya-Serrano, RPS, Jose-Leando Perez-Bosca, JLPB, Francisco Ridocci-Soriano, FRS, Oscar Fabregat-Andres, OFA, Cristina Albiach-Montanana, CAM, Natalia Chacon-Hernandez, NCH, Laura Higueras-Ortega, LHO, Blanca Trejo-Velasco, BTV, Salvador Morell-Cabedo, SMC, Bech-Hanssen, O, Polte, CL, Johnsson, AA, Cederbom, U, Lagerstrand, K, Gao, SA, Cho, E J, Hwang, J W, Park, S J, Yun, H R, Lee, S C, Park, S W, Poilane, M, Cueff, C, Jaafar, P, Jobbe Duval, A, Guijarro, D, Le Tourneau, T, Vaturi, M, Kotler, T, Shapira, Y, Weisenberg, D, Monakier, D, Kazum, S, Sagie, A, Valuckiene, Z, Ovsianas, J, Jurgaityte, J, Jasiskyte, V, Jurkevicius, R, Jenei, C, Muraru, D, Aruta, P, Miglioranza, M H, Cavalli, G, Romeo, G, Peluso, D, Cucchini, U, Iliceto, S, Badano, L P, Yesin, M, Kalcik, M, Gursoy, MO, Gunduz, S, Astarcioglu, MA, Karakoyun, S, Bayam, E, Cersit, S, Ozkan, M, Galuszka, O M, Reinthaler, M, Rutschow, S, Gross, M, Landmesser, U, Kasner, M, Caggegi, A M, Scandura, S, Capranzano, P, Mangiafico, S, Ronsivalle, G, Cannata, S, Farruggio, S, Giaquinta, S, Grasso, C, Tamburino, C, Merchan Cuenda, M, Fuentes Canamero, M E, Bengla Limpo, B, Chacon Pinero, A, Millan Nunez, M V, Nogales Asensio, JM, Lopez Minguez, J R, Garcia Corrales, C, Aranda Lopez, C, Merchan Herrera, A, Merchan Cuenda, M, Fuentes Canamero, M E, Bengla Limpo, B, Millan Nunez, M V, Nogales Asensio, J M, Lopez Minguez, J R, Chacon Pinero, A, Marquez Lozano, P, Garcia Corrales, C, Merchan Herrera, A, Lo Presti, M, Polizzi, V, Pino, GP, Luzi, G, Fiorilli, R, Pergolini, A, Madeo, A, Malouf, J, Buffa, V, Musumeci, F, Islas, F, Almeria, C, Olmos, C, Garcia, E, Nombela, L, De Agustin, JA, Marcos-Alberca, P, Mahia, P, Macaya, C, Perez De Isla, L, Pontes Dos Santos, R A, Correia, E, Cruz, I, Reis, L, Oliveira, M, Faria, R, Magalhaes, P, Domingues, K, Picarra, B, Marques, N, Nemes, A, Domsik, P, Kalapos, A, Sepp, R, Foldeak, D, Borbenyi, Z, Forster, T, Masiha, S, Reis, L, Teixeira, R, Caetano, F, Almeida, I, Trigo, J, Botelho, A, Silva, J, Nascimento, J, Goncalves, L, Cubero Gallego, H, Dobarro Perez, D, Diez De Las Heras, D, Llerena Butron, S, Tobar Ruiz, J, Martin Morquecho, I, Arnold, R, San Roman Calvar, JA, De Gregorio, C, Ando', G, Dattilo, G, Trio, O, Cusma' Piccione, M, Zito, C, Nicotera, A, D'angelo, M, Carerj, S, Ziolkowska, L, Spiewak, M, Malek, L, Boruc, A, Kawalec, W, Alvarez-Ortega, C A, Gonzalez Fernandez, O, Refoyo Salicio, E, Mori, R, Peinado Peinado, R, Lago, M, Trigo, E, Lopez-Sedon, JL, Yuan, L, Zhang, XX, Xie, MX, Jin, XY, Hospital, Union, College, Tongji Medical, Science, Huazhong University of, Technology, Ultrasonography, Department of, Leao, S, Bento, D, Lourenco, C, Domingues, K, Almeida, AR, Marmelo, B, Picarra, B, Lima, R, Faria, R, Azevedo, O, Accadia, M, Irace, L, Abitabile, M, Iengo, R, Arnese, MR, Cocchia, R, Scotto Di Uccio, F, Spadaro, P, Tuccillo, A, Tuccillo, B, Budnik, M, Piatkowski, R, Kochanowski, J, Gaska, M, Glowacka, P, Karolczak, P, Ochijewicz, D, Opolski, G, Stevanovic, A, Dekleva, M, Tsai, W-C, Yang, L-T, Liu, Y-W, Abusalma, Y, O'connell, E, Kenny, C, Mcdonald, K, Mohamed Fereig Hamed, H, Hafez, EMAN, Habib, SHIMAA, Peluso, D, Pigatto, E, Romeo, G, Cucchini, U, Muraru, D, Aruta, P, Cozzi, F, Punzi, L, Iliceto, S, Badano, LP, Podoleanu, C, Coman, I, Jeremias, ZS, Varga, A, Tarta, C, Grancea, I, Tarusi, M, Frigy, A, Carasca, E, Doronzo, A, Piazza, R, Neglia, L, Cervesato, E, Nicolosi, GL, Cassin, M, Upton, R, Aye, C, Davis, E, Packham, A, Arnold, L, Kenworthy, Y, Lamata, P, Lewandowski, A, Leeson, P, Abuladze, GA, Jinjolia, NJ, Ribeiro, JM, Teixeira, R, Fernandes, A, Cassandra, M, Pinto, H, Marques, MG, Raposo, H, Carreira, A, Campos, M, Goncalves, L, De La Chica, JA, Ortiz Garrido, A, Cuenca, V, Conejo, L, Zabala, I, De Mora, M, Petruzzelli, MF, Vasti, MP, Scali, MC, Tramacere, F, D'errico, MP, Gianicolo, EAL, Andreassi, MG, Picano, E, Portaluri, M, Ferrera Duran, C, Gomez-Escalonilla, C, De Agustin, JA, Egido, J, Almeria, C, Simal, P, Marcos, P, Rodrigo, JL, Macaya, C, Perez De Isla, L, Tomaszewski, M, Brzozowski, W, Tomaszewski, A, Poterala, M, Diaz-Pelaez, E, Marciniak, A, Gargallo-Fernandez, P, Barrio-Rodriguez, A, Araco, M, Sharma, R, Wierzbowska-Drabik, K, Kasprzak, JD, Wierzbowska-Drabik, K, Kasprzak, JD, Velasco Del Castillo, S, Anton Ladislao, A, Cacicedo Fernandez Bobadilla, A, Onandia Gandarias, JJ, Sainz, S, Gomez Sanchez, V, Rodriguez Sanchez, I, Garcia Cuenca, E, Zugazabeitia Irazabal, G, Generati, G, Bandera, F, Pellegrino, M, Carbone, F, Labate, V, Alfonzetti, E, Villani, S, Gaeta, M, Ferraro, O, Guazzi, M, Zaborska, B, Smarz, K, Pilichowska-Paszkiet, E, Sikora-Frac, M, Budaj, A, De Diego Soler, O, Ferrer Sistach, E, Vallejo Camazon, N, Lopez-Ayerbe, J, Teis Soley, A, Gual Capllonch, F, Serrano Garcia, S, Bernal Labrador, E, Junca Puig, G, Bayes-Genis, A, Merchan-Gomez, S, Garcia-Sanchez, MJ, Barreiro-Perez, MJ, Arribas-Jimenez, A, Sanchez-Corral, E, Cruz-Gonzalez, I, Martin-Leal, LI, Gajate-Herrero, D, Perdiguero-Martin, PL, Sanchez-Fernandez, PL, Lee, M, Jang, YJ, Lee, YJ, Kim, YS, Chun, WJ, Kang, GH, Oh, JH, Aquila, I, Hinojar, R, Fernandez-Golfin, C, Gonzalez, A, Rincon, LM, Casas, E, Ruiz, S, Barrios, V, Jimenez-Nacher, JJ, Zamorano, JL, Necas, J, Kovalova, S, Perea, GO, Lombardero, M, Henquin, R, Tinetti, M, Corneli, M, Sotaquira, Miguel, Cairati, Mattia, Ettorre, Alessandro, Pepi, Mauro, Tamborini, Gloria, Caiani, Enrico, Sanchez-Martinez, S, Duchateau, N, Erdei, T, Fraser, A, Piella, G, Bijnens, B H, Nestaas, E, Stoylen, A, Fugelseth, D, Hinojar, R, Fernandez-Golfin, C, Esteban, A, Gonzalez-Gomez, A, Garcia-Martin, A, Casas Rojo, E, Pascual-Izco, M, Jimenez-Nacher, JJ, Zamorano, JL, Cerne, A, Berden, P, Agelaki, M, Sundar, S, Antonakaki, D, Grapsa, J, Dawson, D, Papadopoulos, C, Katsivas, A, Nihoyannopoulos, P, Sanchis Ruiz, L, Sanz, M, Bijnens, B, Giraldeau, G, Grazioli, G, Marin, M, Montserrat, S, Sitges, M, Cambronero Cortinas, E, Grapsa, J, Dawson, D, Howard, L, Gin-Sing, W, Valle, A, Corbi-Pascual, MJ, Saez-Mendez, L, Gibbs, S, Nihoyannopoulos, P, Grue, J F, Storve, S, Mjoelstad, O C, Samstad, S O, Dalen, H, Torp, H, Haugen, B O, Yim, D, Mertens, L, Friedberg, MK, Grosse-Wortmann, L, Dragulescu, A, Djikic, DDJ, Simic, SD, Peric, VP, Mujovic, NM, Jankovic, NJ, Marinkovic, MM, Martinez Santos, P, Batlle Lopez, E, Vilacosta, I, Sanchez Sauce, B, De La Rosa Riestra, A, Alonso Bello, J, Espana Barrio, E, Jimenez Valtierra, J, Campuzano Ruiz, R, Rios, Martin, Vrsalovic, M, Hummel, SL, Ghanbari, H, Alpert, C, Oral, H, Kolias, TJ, Mghaieth Zghal, F, Jabberi, Z, Rekik, B, Boudiche, S, Aloui, H, Ben Hlima, M, Ouali, S, Larbi, N, Mourali, MS, Nemes, A, Marton, I, Domsik, P, Kalapos, A, Posfai, E, Modok, S, Borbenyi, Z, Forster, T, Maceira Gonzalez, A M, Monmeneu, JV, Igual, B, Lopez Lereu, MP, Garcia, P, Cosin Sales, J, Maceira Gonzalez, A M, Igual, B, Monmeneu, JV, Lopez Lereu, P, Garcia, MP, Cosin Sales, J, Bala, G, Baudhuin, H, Gillis, K, Remory, I, Krasniqi, A, Lahoutte, T, Devoogdt, N, Droogmans, S, Cosyns, B, Hernot, S, Bulugahapitiya, D S, Bebb, O, Moustafa, A, Vilades, D, Colom Comi, C, Perez-Perez, A, Carreras, F, Leta, R, Pons, G, Jinjolia, NJ, and Abuladze, GA

Abstract

Purpose: To explore the cost effectiveness of expert hand-held echo (HHE) upstream as an alternative to referral for a complete transthoracic echo (TTE) in clinical routine. We hypothized that an upstream HHE approach would prove adequate and cost effective in terms of - Decrease the numbers of required TTE - Fewer revisits to the outpatient unit - Shorten the length of admission - Increase the number of higly specialized echoes, i.e. stress echo, transesophageal echoes - Shorten the time to final diagnosis and decrease the concerns for the patient who is forced to wait for survey and results at complete TTE. Methods: In this study, a HHE scanner (V-scan, GE Health care) was kept available for the senior consultants with level 3 TTE certification, for use in patients where a TTE was indicated. HHE was performed in different clinical scenarios such in the emergency room, during consultation of inpatients or in the clinic of outpatients. The results of HHE was documented in the patient record under a heading and can directly be found upon request. The length of hospital stay during a representative week, is compared between patients who have not undergone HHE with patients undergoing HHE. Results: Out of a total of 94 patients examined with HHE, 71 patients were not in need of a complete TTE. Additional 11 patients received a more rapid investigation i.e stress-echo, transesophageal echocardiography or other investigations that would otherwise have been delayed because of waiting for the complete TTE. 12 patients were in need of a complete TTE for a more precise analysis. In the heart clinic of Danderyds hospital approximately 18 inpatients were examined with a complete TTE every ordinary week and that postpone the day of submission from hospital among approximately 6 patients a week. Every day of care in hospital cost 445 € in an ordinary ward and 981 € in the heart intensive care unit. This means there is a cost benefit of approximately 3741 € every week if it is possible to prevent this postponing of submission. Conclusions: Upstream HHE in clinical routine was in the setting of this study highly cost-effective, decreasing the need of TTE to a great extent, and leading to quicker diagnosis, shorter hospital stays and less anxiety in patients during the waiting time for a complete TTE and before a response is received.

Published
2015
Full Text
View/download PDF

15. Echocardiographic Prediction of Successful Weaning From Venoarterial Extracorporeal Membrane Oxygenation.

Author

Alonso-Fernandez-Gatta M, Merchan-Gomez S, Gonzalez-Cebrian M, Diego-Nieto A, Gonzalez-Martin J, Toranzo-Nieto I, Barrio A, Martin-Herrero F, and Sanchez PL

Subjects
Humans, Stroke Volume, Ventricular Function, Left, Shock, Cardiogenic therapy, Echocardiography, Retrospective Studies, Extracorporeal Membrane Oxygenation
Abstract

Background: Weaning from venoarterial extracorporeal membrane oxygenation (VA-ECMO) support fails in 30% to 70% of patients., Objective: To explore the utility of echocardiographic parameters in predicting successful disconnection from VA-ECMO., Methods: Patients receiving VA-ECMO in a referral hospital were included. The relationships between echocardiographic parameters during the weaning trial and weaning success (survival > 24 hours after VA-ECMO explant and no death from cardiogenic shock, heart failure, or cardiac arrest during the hospital stay) and survival were evaluated., Results: Of 85 patients included, 61% had successful weaning. Parameters significantly related to weaning success were higher left ventricular ejection fraction (LVEF; 40% in patients with weaning success vs 30% in patients with weaning failure, P = .01), left ventricular outflow tract velocity time integral (15 cm vs 11 cm, P = .01), aortic valve opening in every cycle (98% vs 91% of patients, P = .01), and normal qualitative right ventricular function (60% vs 42% of patients, P = .02). The LVEF remained as an independent predictor of weaning success (hazard ratio, 0.938; 95% CI, 0.888-0.991; P = .02). An LVEF >33.4% was the optimal cutoff value to discriminate patients with successful weaning (area under the curve, 0.808; sensitivity, 93%; specificity, 72%) and was related to higher survival at discharge (60% vs 20%, P < .001)., Conclusion: Among weaning trial echocardiographic parameters, LVEF was the only independent predictor of successful VA-ECMO weaning. An LVEF >33.4% was the optimal cutoff value to discriminate patients with successful weaning and was related to final survival., (©2022 American Association of Critical-Care Nurses.)

Published
2022
Full Text
View/download PDF

16. Short-term mechanical circulatory support in elderly patients.

Author

Alonso-Fernandez-Gatta M, Merchan-Gomez S, Toranzo-Nieto I, Gonzalez-Cebrian M, Diego-Nieto A, Barrio A, Martin-Herrero F, and Sanchez PL

Subjects
Aged, Humans, Retrospective Studies, Shock, Cardiogenic etiology, Shock, Cardiogenic surgery, Stroke Volume, Treatment Outcome, Ventricular Function, Left, Heart-Assist Devices adverse effects, Percutaneous Coronary Intervention adverse effects
Abstract

Background: Age over 70 years seems to confer poor prognosis for patients under mechanical circulatory support (MCS). Advanced age is usually a relative contraindication. Our objective was to assess the impact of age on survival of patients with short-term MCS., Methods: Retrospective analysis of ≥70-year-old patients supported with veno-arterial extracorporeal membrane oxygenation (VA-ECMO) or Impella CP® due to cardiogenic shock and other situations of hemodynamic instability in a referral hospital (elderly group), compared with younger patients (<70 years). We analyze factors associated with survival in elderly group., Results: Out of 164 short-term MCS implants from 2013 to October 2020, 45 (27.4%) correspond to ≥70-year-old patients (73.3% VA-ECMO; 26.7% Impella CP®), 80% as bridge to recovery and 15.6% for high-risk percutaneous coronary intervention (PCI). We found no significant differences in complications developed between both groups. Survivals at discharge (40% vs. 43.7%, p = 0.403) and at follow-up (median 13.6 [30] months) were similar in elderly and young patients (35.6% vs. 37.8%, log-rank p = 0.061). Predictive factors of mortality in elderly patients were peripheral artery disease (p = 0.037), higher lactate (p = 0.003) and creatinine (p = 0.035) at implant, longer cardiac arrest (p = 0.003), and worse post-implantation left ventricular ejection fraction (p = 0.003). Patients with indication of MCS for high-risk PCI had higher survival compared to other indications (p = 0.013)., Conclusion: Short-term MCS with VA-ECMO or Impella CP® in elderly patients may be a reasonable option in hemodynamic compromise situations as bridge to recovery or elective high-risk PCI, without a significant increase in complications or mortality. Age should not be an absolute contraindication, but careful selection of candidate patients is necessary., (© 2021 International Center for Artificial Organs and Transplantation and Wiley Periodicals LLC.)

Published
2022
Full Text
View/download PDF

17. Post-traumatic stress disorder symptoms after veno-arterial extracorporeal membrane oxygenator support.

Author

Alonso-Fernandez-Gatta M, Gonzalez-Cebrian M, Merchan-Gomez S, Toranzo-Nieto I, Diego-Nieto A, and Sanchez PL

Subjects
Adult, Cross-Sectional Studies, Humans, Oxygenators, Membrane, Retrospective Studies, Extracorporeal Membrane Oxygenation adverse effects, Stress Disorders, Post-Traumatic epidemiology, Stress Disorders, Post-Traumatic etiology
Abstract

Background: Post-traumatic stress disorder (PTSD) is a common long-term outcome after intensive care of critical illness., Objectives: Assess the prevalence and factors associated to PTSD after veno-arterial extracorporeal membrane oxygenation (VA-ECMO) support., Methods: Retrospective analysis of admission data and cross-sectional assessment of PTSD symptoms in adult survivors from admission requiring VA-ECMO support in a referral hospital. People were screened through abbreviated Impact of Event Scale-6 (IES-6)., Results: Out of 135 VA-ECMO implants performed from 2013 to 2020, 48 (35.6%) patients survived the admission. After a median follow-up of 31.4 [36] months, 34 survivors responded the questionnaire. All patients required sedation and invasive mechanical ventilation. Up to 29.4% of patients had PTSD symptoms. Patients with altered IES-6 items had passed a longer time since admission in ICCU (44±15 vs 30±20 months, p = 0.034). No baseline characteristic or admission-related variables were correlated with IES-6 except the lower time under mechanical ventilation (6.5 [8.5] vs. 8.5 [21] days, p = 0.044)., Conclusions: Survivors from admission requiring VA-ECMO support show high prevalence of PTSD symptoms, appearing more frequently when more time has elapsed since admission. Special attention should be paid to psychological symptoms after VA-ECMO support., (Published by Elsevier Inc.)

Published
2021
Full Text
View/download PDF

18. Levosimendan in veno-arterial extracorporeal membrane oxygenator supported patients: Impact on the success of weaning and survival.

Author

Alonso-Fernandez-Gatta M, Merchan-Gomez S, Gonzalez-Cebrian M, Diego-Nieto A, Alzola E, Toranzo-Nieto I, Barrio A, Martin-Herrero F, and Sanchez PL

Subjects
Case-Control Studies, Female, Humans, Male, Middle Aged, Retrospective Studies, Shock, Cardiogenic mortality, Shock, Cardiogenic therapy, Cardiotonic Agents therapeutic use, Extracorporeal Membrane Oxygenation, Simendan therapeutic use
Abstract

Weaning failure and mortality rates in veno-arterial extracorporeal membrane oxygenation (VA-ECMO) supported patients are significant. Small studies suggest the possible usefulness of levosimendan in this environment, especially in postcardiotomy shock. We performed a retrospective analysis of VA-ECMO implants in a referral hospital comparing weaning failure and survival of patients treated with levosimendan with a control group. From 2013 to May 2020, 123 VA-ECMO for several indications were implanted. Levosimendan was administered in 23 patients (18.7%) with good tolerance. Levosimendan was used more frequently in cardiogenic shock due to acute coronary syndrome indication, and in patients with lower left ventricular ejection fraction (LVEF) at the implant. No significant differences were found in success of ECMO weaning (60.9% levosimendan group vs. 44% non-levosimendan group, P = .169) despite worse LVEF in levosimendan group. Survival at follow-up (20.6 [58] months) was higher in the group that received levosimendan, although without finding statistically significant differences (47.8% vs. 32.0%, log rank P = .124). Levosimendan can be safely administered during VA-ECMO support. Patients receiving levosimendan were weaned similarly from circulatory support despite worse LVEF. Its use did not influence in short- and medium-term survival. Randomized studies are needed to evaluate the levosimendan impact in this indication., (© 2021 International Center for Artificial Organs and Transplantation and Wiley Periodicals LLC.)

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results